Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
CA 2382204 A1 · Owner: Urogene · Inventors: Cussenot, Olivier; Villette, Jean-Marie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for producing a non-human A mammal with a prostatic tumor. The invention also relates to a prostatic tumor and an established cell line which can form a prostatic tumor in dogs after grafting has occurred. The invention further relates to specific monoclonal antibodies of prostatic tumoral cells and to the use thereof in diagnosis or therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 23, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 23, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 23, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.